Gastroenterology

Article	Citations
An Unusual Case of Gallbladder Emergency	587
A Model to Eliminate Viral Hepatitis Infection in Migrants: A Prospective, Multicenter Study in Southern Italy	526
Interleukin 21 Drives a Hypermetabolic State and CD4+ T-Cell–Associated Pathogenicity in Chronic Intestinal Inflammation	490
SOX9 Expression Pattern and Its Prognosis in Gastric Cancer Should be Fully Evaluated	472
TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease	442
In Memoriam: David A. Ahlquist, MD	389
713f Histologic Activity in Ulcerative Colitis Patients Achieving Endoscopic Healing is Associated with Higher Rate of Relapse and a Distinct Mucosal Microbial and Transcriptional Profile	366
Editorial Board	358
Elsewhere in The AGA Journals (Preview Section)	339
Spotlight	313
Mo1129 PHASE 3 BIOMARKER STUDY FOR HCC SURVEILLANCE USING A NOVEL HES V2.0 ALGORITHM. A PROSPECTIVE COLLECTION WITH RETROSPECTIVE BLINDED EVALUATION	289
Trends in Industry Payments to Gastroenterologists and Hepatologists in the United States From 2014 to 2020	287
An Atypical Case of Acute Upper Gastrointestinal Bleeding	272
Cover 1	238
Information for Authors and Readers	214
Reply	198
Elsewhere in The AGA Journals	196
Probing the Microbiome to Predict Response to Biologic Therapy in Inflammatory Bowel Disease—One Step Closer to Precision Medicine?	192
462 FUNCTIONAL DYSPEPSIA AND GASTROPARESIS ARE INTERCHANGEABLE SYNDROMES WITH COMMON CLINICAL AND PATHOLOGICAL FEATURES	188
Clinical Decision Support Tool: IBS Treatment	184
Refractory Constipation in a 53-Year-Old Man	183
Table of Contents	182
Cover 1	180
Editorial Board	174
The Potential of Radiomics in the Assessment of Intestinal Fibrosis in Crohn’s Disease	170

Sa1247 NEW INSIGHTS ON THE MECHANISM OF ACTION OF HYOSCINE BUTYLBROMIDE (HBB) IN THE HUMAN COLON: HBB MODULATES EFFECT OF NEURONAL AND NON-NEURONAL ACETYLCHOLINE	169
Sa1244 BIOPHYSICAL PROPERTIES OF GASTROINTESTINAL SMOOTH MUSCLE CELL MECHANOGATED CHANNEL TMEM63A	167
224 EXTERNAL VALIDATION OF A DEEP LEARNING MODEL FOR WHOLE SLIDE IMAGE ANALYSIS IN THE HISTOLOGIC DIAGNOSIS OF DYSPLASTIC BARRETT'S ESOPHAGUS	165
288 OPTICAL COHERENCE TOMOGRAPHY GUIDED LASER CAPTURING OF GASTROINTESTINAL TRACT TISSUE FOR GENOMIC ANALYSIS	164
699 SAFETY OUTCOMES AND CONCOMITANT MEDICATION CHANGES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE BEING TREATED WITH RBX2660 FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION	163
855 CAN CYTOSPONGE HELP TRIAGE PATIENTS WHO CAN BE DISCHARGED FROM BARRETT'S SURVEILLANCE PROGRAMMES? A 2-YEAR SINGLE SITE UK STUDY	162
Su1807 IBD MEDICATION USE IN PREGNANCY IS ASSOCIATED WITH A LOW RATE OF CONGENITAL ANOMALIES IN NEONATES: RESULTS FROM AN ANALYSIS OF THE BRITISH COLUMBIA POPULATION DATABASE.	155
Su1776 EARLY AND RAPID USTEKINUMAB ADOPTION FOR INFLAMMATORY BOWEL DISEASE TREATMENT	152
Tu1103 CROSS-SECTIONAL VS. LONG-TERM ADHERENCE TO COLORECTAL SCREENING IN A LARGE VA COHORT	152
Mo1532 ANTIVIRAL TREATMENT AND ITS RESPONSE REDUCE DEVELOPMENT OF DEMENTIA AMONG HEPATITIS C VIRUS INFECTED PATIENTS IN THE U.S.	149
Mo1501 A NOVEL PROGNOSTIC MODEL USING DONOR AND RECIPIENT CHARACTERISTICS TO PREDICT EARLY POST-TRANSPLANT MORTALITY IN PATIENTS WITH ACUTE LIVER FAILURE	144
Tu1924 FORGOTTEN BUT STILL RELEVANT: VITAMIN C DEFICIENCY IN CHILDREN WITH COMPLEX MEDICAL PROBLEMS	143
Tu1493 RISK FACTORS OF DEVELOPING NONALCOHOLIC FATTY LIVER DISEASE FOLLOWING PANCREATIC RESECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS	141
Tu1525 ALL THE MORE PEOPLE TO SCREEN: A LASTING IMPACT OF A QUALITY IMPROVEMENT INITIATIVE TO INCREASE HEPATITIS C SCREENING IN AN UNDERINSURED POPULATION	141
991 COST-EFFECTIVENESS OF RISK-STRATIFIED POST-HEPATECTOMY CARE PATHWAY IMPLEMENTATION	141
Sa1563 DEVELOPMENT AND VALIDATION OF A NOMOGRAM TO BETTER PREDICT SARCOPENIA IN NAFLD PATIENTS: AN INSIGHT FROM THE NHANES 2017-2018	140
228 LAPAROSCOPIC DISTAL PANCREATECTOMY BY RADICAL ANTEGRADE MODULAR PANCREATOSPLENECTOMY (RAMPS)	139
1097 PATIENTS ADMITTED WITH ACUTE CHOLECYSTITIS AND ASSOCIATED COVID 19 HAD LESS RATES OF SAME ADMISSION CHOLECYSTECTOMY BUT NOT INCREASED MORTALITY	138
Su1598 IS THERE A ROLE FOR PRE-EMPTIVE TIPS IN ACUTE VARICEAL BLEEDING? REAL WORLD DATA FROM A LOCAL ASIAN COHORT	136
Tu1750 A HIGHER VISCERAL ADIPOSE TISSUE BURDEN IS ASSOCIATED WITH HIGHER INFLIXIMAB CLEARANCE IN INFLAMMATORY BOWEL DISEASE	136
530 COMPARISON OF OUTCOMES FOR PATIENTS UNDERGOING SADI VS. RYGB IN 2020 AND 2021	135
Sa2007 INSURANCE DELAYS BIOLOGIC AND SMALL MOLECULE TREATMENT OF PEDIATRIC IBD IN TERTIARY CARE CENTER	131
Sa1916 THE EFFECT OF TEDUGLUTIDE ON THE UTILIZATION OF ENTERAL NUTRIENTS FOR THE SYNTHESIS OF HEPATIC, PANCREATIC AND MUCOSAL PROTEINS IN PATIENTS WITH SHORT BOWEL SYNDROME	129
Sa2001 GROWTH OUTCOMES OF IV ANTI-TNF BIOSIMILARS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE	126
Sa1834 VISCERAL ADIPOSITY INDEPENDENTLY PREDICTS TIME TO FLARE IN INFLAMMATORY BOWEL DISEASE, BUT BMI DOES NOT	125
CME Exam 3: Abdominal Pain in a Young Adult	123
Sa1779 THE EPIDEMIOLOGY AND CHARACTERISTICS OF DE NOVO IBD AFTER SOLID ORGAN OR HEMATOPOIETIC STEM CELL TRANSPLANT BETWEEN 2011-2021: A LARGE POPOULATION-BASED STUDY	123
Sa1829 TEMPORAL TRENDS IN 30-DAY AND 90-DAY HOSPITAL RE-ADMISSION RATES AMONG PERSONS WITH CROHN'S DISEASE IN THE POSTBIOLOGIC ERA: A POPULATION-BASED STUDY FROM A LARGE CANADIAN PROVINCE	123
Sudden Fatal Abdominal Pain in an Old Man With Chronic Constipation	122
A Seldomly Reported Cause of Acute Abdominal Pain and Infection	122
Nausea, Vomiting, and Abdominal Distention After Atrial Fibrillation Therapy	120
Efficacy and Safety of Drugs for Gastroparesis: Dopamine Receptor Antagonists Should Not Be Considered as a Single Pharmacologic Entity	118
Conventional Endoscopic Mucosal Resection Versus Underwater Endoscopic Mucosal Resection: Is the Choice Straightforward?	118
The Impact of the COVID-19 Pandemic on Barrett’s Esophagus and Esophagogastric Cancer	116
713e Longitudinal Analysis in A HNF4AΔIEC Mouse Colitis Model Reveals that Preclinical Flaring is Associated with Increased Akkermansia muciniphila Levels in the Gut Microbiome	110
Ulcerative colitis—Maintanance of Remission With the Probiotic Escherichia coli Strain Nissle 1917	110
775f The Introduction of Faecal Immunochemical Testing as a Triaging Tool for Colorectal Cancer Investigation During the COVID-19 Pandemic. A Service Evaluation and Report.	110
Inflammatory Bowel Disease, Celiac Disease, and Primary Sclerosing Cholangitis: Is There a Link?	110
Reply	108
1042 MEDICATIONS AND RISK OF MICROSCOPIC COLITIS: A NATIONWIDE COHORT STUDY	107
560 SELECT AMINO ACIDS (AA-ORS) IMPROVE ELECTROLYTE AND FLUID ABSORPTION IN A RODENT DIARRHEA MODEL	107
756 ELEVATED DIACYLGLYCEROL O-ACYLTRANSFERASES 1 AND 2 (DGAT1/2) REINFORCE A NEGATIVE REGULATORY LOOP OF LIPID DROPLETS AND FOXO3 TRANSCRIPTION FACTOR THAT DRIVES METABOLIC AND TUMEROGENIC REMODELING	106
1123 LOSS OF INTESTINAL EPITHELIAL DUOX2 SIGNALING IS ACCOMPANIED BY A REDUCTION IN AKKERMANSIACEAE AND PROMOTES THE DEVELOPMENT OF METABOLIC SYNDROME IN A MICROBIOME-DEPENDENT MANNER.	105
1136 IMPROVED HEPATOCELLULAR CARCINOMA SURVEILLANCE WITH ANALYTICAL QUALITY IMPROVEMENT MEASURES, ELECTRONIC MEDICAL RECORD ALERTS COMBINED WITH PATIENT EDUCATION AND OUTREACH FOR PATIENTS WITH CIRRHO	105
954 MESENCHYMAL STEM CELLS AMELIORATE INFLAMMATION IN AN EXPERIMENTAL MODEL OF CROHN'S DISEASE VIA THE MESENTERY	103
934 GERD-INDUCED ALTERATIONS IN HYDROGEN SULFIDE SIGNALING AS THE FUNDAMENTAL MECHANISM OF BARRETT'S ESOPHAGUS PATHOGENESIS	102
140 FRAILTY IS ASSOCIATED WITH HIGHER IN-HOSPITAL MORTALITY, COMPLICATIONS AND HOSPITAL COST IN PATIENTS ADMITTED WITH DECOMPENSATED CIRRHOSIS: A NATIONWIDE STUDY.	102
1027 EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB REINDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER T	102
478 NON-CANONICAL ACTIVIN A SIGNALING STIMULATES CONTEXTDEPENDENT AND CELLULAR-SPECIFIC OUTCOMES IN CRC TO PROMOTE TUMOR CELL MIGRATION AND TOLERANCE	102
Intrahepatic Bile Duct Foreign Body With Cholangitis After Pylorus-preserving Pancreatoduodenectomy: Is It a Fish Bone?	100

Aldehyde “Adduction” Explains Synergy of Smoking and Alcohol in Promoting Pancreatitis	100
Sa1526 INTERNAL BILIARY STENTS AND BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATION: 16 YEARS OF EXPERIENCE IN A SINGLE CENTER	100
Sa1525 RECENT IMMIGRANTS AND REFUGEES HAVE EQUAL RATES OF LIVER TRANSPLANTATION IN THE SETTING OF UNIVERSAL HEALTHCARE	98
Sa1193 RATIONALE FOR NEW SURVEILLANCE GUIDELINES FOR PATIENTS AT RISK OF PERITONEAL METASTASIS FROM COLON CANCER	97
Sa1142 EFFECTS OF BIOLOGIC THERAPY IN PRIMARY SCLEROSING CHOLANGITIS WITH AND WITHOUT INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS	97
Mo1508 HOSPITAL TEACHING STATUS AND OUTCOMES IN PATIENTS WITH ESOPHAGEAL VARICEAL BLEEDING- A RETROSPECTIVE COHORT STUDY	96
489 EATING HABITS AND SPECIFIC FOODS AND THEIR ASSOCIATION WITH GASTROINTESTINAL SYMPTOMS IN PATIENTS WITH FUNCTIONAL DYSPEPSIA AND IBS	96
Sa1118 CHARACTERIZING DISEASE BURDEN AND RISK FACTORS IN LARYNGOPHARYNGEAL REFLUX DISEASE	96
157 NEOPLASTIC PROGRESSION OF BARRETT'S ESOPHAGUS AMONG ORGAN TRANSPLANT RECIPIENTS: A CASE-CONTROL STUDY	96
Tu1452 ARTIFICIAL INTELLIGENCE ASSISTANCE OF PANCREATIC EXOCRINE INSUFFICIENCY EVALUATION IN CHRONIC PANCREATITIS FROM CONTRAST-ENHANCED CT	95
Mo1521 THE GLOBAL BURDEN OF ALCOHOL-ASSOCIATED CIRRHOSIS AND CANCER IN YOUNG ADULTS	93
Mo1532 PRESENCE OF MENTAL HEALTH DISORDERS IN PATIENTS WITH ALCOHOL USE REDUCES THE CHANCES FOR HEPATOLOGY REFERRAL DESPITE A HIGH FIB-4 INDEX	93
Mo1886 VALIDATION OF THE USE OF ARTIFICIAL INTELLIGENCE FOR CLASSIFICATION OF ULCERATIVE COLITIS VS CROHN'S DISEASE IN PEDIATRIC PATIENTS	93
Su1559 EFFECT OF ALCOHOL CONSUMPTION ON PEMAFIBRATE TREATMENT IN PATIENTS WITH FATTY LIVER AND HYPERTRIGLYCERIDEMIA	93
Su1847 COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: IMPACT OF MODERATE-TO-SEVERE CROHN'S DISEASE SYMPTOMS ON HEALTH CARE PROFESSIONAL TREATMENT DECISIONS IN THE UNITED STATES	92
Tu1888 METFORMIN IMPROVES INFLAMMATORY BOWEL DISEASE OUTCOMES IN PATIENTS WITH COMORBID TYPE 2 DIABETES MELLITUS	92
Sa1225 DEVELOPMENT OF A PERSONALIZED HUMAN PANETH CELL MODEL USING INTESTINAL ORGANOIDS	91
Mo1269 PERSONALIZED INTERVENTIONS FOR ESOPHAGEAL DYSMOTILITY PREVENTS EXTRA-ESOPHAGEAL COMPLICATIONS AND IMPROVES SURGICAL OUTCOMES IN LUNG TRANSPLANT RECIPIENTS	90
Tu1617 INTEGRATION OF NORMOTHERMIC MACHINE PERFUSION IN A LIVER TRANSPLANT PROGRAM REDUCES WAITLIST TIME AND MORTALITY: A TWO-CENTER/ONE ENTERPRISE MODERN EXPERIENCE	90
Mo1750 EXPLORING THE RELATIONSHIP BETWEEN THE MEDITERRANEAN DIET AND BARRIER FUNCTION IN ULCERATIVE COLITIS	89
Tu1958 INVESTIGATION OF FEEDING TUBE LONGEVITY FOR PERCUTANEOUS ENDOSCOPIC GASTROJEJUNOSTOMY (PEGJ) VS. DIRECT PERCUTANEOUS ENDOSCOPIC JEJUNOSTOMY (DPEJ) TUBES	89
Mo1592 ANALYSIS OF INPATIENT ADMISSIONS AND MORTALITY RATE OF AUTOIMMUNE HEPATITIS (AIH), PRIMARY BILIARY CIRRHOSIS (PBC), AND PRIMARY SCLEROSING CHOLANGITIS (PSC): A UNITED STATES NATIONWIDE STUDY.	88
Sa1611 HEPATITIS B VIRUS REACTIVATION IN CANCER PATIENTS RECEIVING CHEMOTHERAPY – A SYSTEMATIC REVIEW AND META-ANALYSIS	88
Sa1749 ADRENAL INSUFFICENCY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH GLUCOCORTICOIDS: A META-ANALYSIS	87
Su1040 EFFECTS OF AN INTERVENTIONAL RADIOLOGY GUIDED TRAINING PROGRAM ON PARACENTESIS COMPETENCY AMONG INTERNAL MEDICINE RESIDENTS	87
Sa2035 IBD PATIENT-DERIVED INTESTINAL ORGANOID PLATFORM FOR PRECISION MEDICINE	87
Su1948 APRAGLUTIDE TREATMENT IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC) IS ASSOCIATED WITH INCREASED ORAL INTAKE AND IMPROVED ENERGY AND CARBOHYDRATE ABSORP	86
531 THE CONDITIONAL MUTATED RAD21 KNOCK-IN MOUSE MODEL FOR CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: NEUROCHEMICAL AND FUNCTIONAL ANALYSIS	86
Sa1582 IN A NATIONAL COHORT OF VETERANS WITH SBP, SECONDARY SBP PROPHYLAXIS LINKS WITH GREATER SBP RECURRENCE COMPARED TO THOSE NOT STARTED ON PROPHYLAXIS AND THIS BURDEN IS WORSENING OVER TIME	86
436 POSTOPERATIVE COMPLICATIONS TREND AFTER ILEO-J-POUCH-ANAL ANASTOMOSIS FOR INFLAMMATORY BOWEL DISEASE. A SYSTEMATIC LITERTURE REVIEW	86
829 UNDERSTANDING FRAGMENTED PANCREATIC CANCER CARE IN PATIENTS RECIEVING NEOADJUVANT THERAPY: ARE SOCIODEMOGRAPHIC DISPARITIES PREDICTIVE OF PATIENTS RECEIVING FRAGMENTED CARE?	84
533 REGIONAL MICROBIOTA MISMATCHES FROM FECAL MICROBIOTA TRANSPLANTS DRIVE PERSISTENT, OFF-TARGET CONSEQUENCES TO THE HOST	83
Tu2022 DEVELOPMENT OF AN ARTIFICIAL INTELLIGENCE MODEL TO IDENTIFY DUODENAL POLYPS IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS	82
847 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): CONCORDANCE OF CLINICAL PROFILES AND NON-INVASIVE TESTS PERFORMANCE	81
Su1816 CAPILLARY BLOOD BASED SELF COLLECTION DEVICE FOR INFLIXIMAB THERAPEUTIC DRUG MONITORING	81
Su1524 GENETIC BIOMARKERS PREDICTING PROGNOSIS IN PATIENTS WITH CHOLANGIOCARCINOMA; A BIOINFORMATICS APPROACH STUDY	81
Sa2047 MACHINE LEARNING-BASED INTEGRATION DEVELOPS A PLASMA EXTRACELLULAR VESICLE LONG RNA SIGNATURE FOR THE DISTINCTION OF CHRONIC PANCREATITIS SUBJECTS FROM DISEASE AND HEALTHY CONTROL SUBJECTS	80
Tu1996 USE OF AN AUTOMATED, DEEP LEARNING SOFTWARE TO EVALUATE BODY COMPOSITION INCLUDING SKELETAL MUSCLE MASS AND VISCERAL ADIPOSITY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE	80
Tu1923 DYSREGULATED LIPIDS ARE ASSOCIATED WITH GUT MICROBIAL DYSBIOSIS IN AUTOIMMUNE SCURFY MICE	80
Mo1591 ASSESSMENT OF THE DRUG-DRUG INTERACTION POTENTIAL OF ELAFIBRANOR WITH INDOMETHACIN IN HEALTHY ADULT MALE PARTICIPANTS: AN OPEN-LABEL PHASE I TRIAL	80
Tu1011 CAUSAL EFFECTS OF IMPLEMENTATION OF THE AFFORDABILITY CARE ACT ON GASTRIC CANCER SURVIVAL: A DIFFERENCE-IN-DIFFERENCES ANALYSIS OF TWO U.S. STATES	79
EP41 SYSTEM-SPECIFIC MEAN NOCTURNAL BASELINE IMPEDANCE CUT OFF VALUES ARE DIFFERENT THAN COMMONLY PUBLISHED	79
Mo1823 CANNABIS USE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH ACTIVE ENDOSCOPIC INFLAMMATION	79
63 IMPACT OF END-ILEOSTOMY VERSUS ILEAL POUCH-ANAL ANASTOMOSIS ON GRAFT-SURVIVAL FOLLOWING LIVER TRANSPLANTATION FOR PRIMARY SCLEROSING CHOLANGITIS	78
Mo2048 TRYPTOPHAN METABOLITES AS PREDICTIVE BIOMARKERS FOR DIETARY THERAPY OUTCOMES IN PEDIATRIC CROHN'S DISEASE	78
464 TUMOR INTRINSIC METTL5 EXPRESSION DRIVES IMMUNE EVASION TO PROMOTE INTRAHEPATIC CHOLANGIOCARCINOMA PROGRESSION	78
Mo1394 LAPAROSCOPIC GASTROPEXY WITH SOFT TISSUE ANCHOR IS A SAFE AND DURABLE TREATMENT FOR HIATAL HERNIAS DURING OR AFTER SLEEVE GASTRECTOMY	78
Su1648 ACUTE AND LONG-TERM EFFECTS OF HEARTFULNESS MEDITATION ON PSYCHOLOGICAL OUTCOMES AND THE ENDOCANNABINOID SIGNALING SYSTEM IN CYCLIC VOMITING SYNDROME USING AN APP	77
823 TOTAL NEOADJUVANT THERAPY IN DISTAL PANCREATIC ADENOCARCINOMA: DOES LOCATION IMPACT THERAPY RESPONSE?	76
Tu1017 THE IMPACT OF GENDER AND SEX ON HEALTHCARE UTILIZATION AND SPENDING IN ADULTS WITH IRRITABLE BOWEL SYNDROME	75
Mo1630 ASSESSMENT OF APRI AND FIB-4 PERFORMANCE TO ASSESS FOR ADVANCED LIVER FIBROSIS IN A NATIONALLY REPRESENTATIVE COHORT	75
Tu1121 OSTEOGENESIS IMPERFECTA PATIENTS REPORT GASTROINTESTINAL COMPLAINTS NO MORE THAN THE GENERAL POPULATION: THE BRIGHTSIDE OF A RARE GENETIC DISORDER	75
Su1046 PREVALENCE OF AND RISK FACTORS FOR LOSS TO FOLLOW-UP AFTER HIGH-RESOLUTION ESOPHAGEAL MANOMETRY	75
752 A GLOBAL SURVEY ON THE MANAGEMENT OF ALCOHOL-ASSOCIATED HEPATITIS	75
Sa2039 NOVEL KEYSTONE SPECIES OF GUT BACTERIOME AND VIROME IN EARLY LIFE ARE ALTERED IN PRETERM INFANTS AND IMPLICATED IN CHILDHOOD DISEASES	75
Su1520 PREDICTORS OF ADVERSE EVENTS AND COMPLICATIONS IN CIRRHOTIC PATIENTS WITH RHEUMATOID ARTHRITIS	75
Mo1234 RISK OF INTERVAL GASTRIC CANCER IN PATIENTS WITH INVISIBLE LOW-GRADE GASTRIC DYSPLASIA: A POPULATION-BASED LONGITUDINAL COHORT STUDY	74
Mo1235 PREVALANCE AND ASSOCIATIONS OF GASTRIC HIGH-GRADE DYSPLASIA IN PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS: A TERTIARY CARE CENTER EXPERIENCE	74
Mo1841 RATES OF ESCALATION TO ADVANCED THERAPY IN PATIENTS WITH ULCERATIVE PROCTITIS AT SIX MONTHS, ONE YEAR, AND TWO YEARS POST DIAGNOSIS	74
Tu1559 RISK OF HEPATOCELLULAR CARCINOMA AMONGST SUBCENTIMETER NODULES ON SURVEILLANCE ULTRASOUND: A SYSTEMATIC REVIEW	74
820 FASTING RELATED AUTOPHAGY DECREASES THE SEVERITY OF ACUTE PANCREATITIS IN A RODENT MODEL OF SEVERE DISEASE	74
163 DELAYED RECURRENCE OF REFLUX SYMPTOMS AFTER MAGNETIC SPHINCTER AUGMENTATION: CHARACTERIZING THE PATIENTS AND ROLE OF ENDOSCOPIC DILATION	73
Mo1337 PREOPERATIVE CHEMORADIOTHERAPY FOR ESOPHAGEAL CARCINOMA: A SINGLE CENTER 10-YEAR OUTCOMES OF CROSS VS MODIFIED CROSS RADIATION.	72
Su1050 THE IMPACT OF MULTIDISCIPLINARY PANCREAS CONFERENCE ON DIAGNOSIS AND MANAGEMENT	71
EP179 LIQUID BIOPSY FOR PANCREATICOBILIARY CANCER; MOLECULAR BARCODING VERSUS DEEP SEQUENCING	70
1278 THE CHALLENGE OF BENIGN INCIDENTALOMAS: IDENTIFYING AND MAPPING THE NATURAL COURSE OF HIATAL HERNIAS	70
Su1054 LIMITED UTILITY OF INCLUDING THE CARDIA IN ROUTINE GASTRIC MAPPING: A QUALITY IMPROVEMENT PROJECT	70
Mo1268 ENDOSONOGRAPHIC CHARACTERISTICS OF THE LOWER ESOPHAGEAL SPHINCTER IN ACHALASIA PATIENTS COMPARED TO NORMAL INDIVIDUALS AND THEIR ASSOCIATIONS WITH MANOMETRIC FINDINGS AND POST-MYOTOMY RESPONSE	70
Su1538 COMPARING ULTRASOUND-BASED MEASURES OF THE INTERNAL JUGULAR VEIN AND THE INFERIOR VENA CAVA AS ESTIMATORS OF CENTRAL VENOUS PRESSURE IN PATIENTS WITH CIRRHOSIS.	69
EP125 IS THERE A DIFFERENCE IN THE GASTRIC EMPTYING TIME ACCORDING TO THE FD SUBTYPE?	69
Tu1086 PROMOTING THE AUSTRALIAN NATIONAL BOWEL CANCER SCREENING PROGRAM IN GENERAL PRACTICE: ENABLING A CULTURE OF PREVENTION WITHIN A CLINICAL SETTING	69
Tu1995 COMPARISON OF ADENOMA DETECTION RATE IN SCREENING OR SURVEILLANCE COLONOSCOPY USING ARTIFICIAL INTELLIGENCE VS STANDARD COLONOSCOPY: A META-ANALYSIS OF RANDOMIZED CONTROLLED STUDIES	68
Tu1099 ORAL ANTICOAGULATION IS NOT ASSOCIATED WITH IMPROVED SURVIVAL IN PATIENTS WITH COLORECTAL CANCER	68
Mo1270 ABNORMAL DISTENSION-CONTRACTION PROFILE IN PATIENTS WITH FUNCTIONAL DYSPHAGIA – STUDY USING A VISCOUS BOLUS	67
Su1600 RISK SCORING SYSTEMS TO PREDICT IN-HOSPITAL MORTALITY IN PATIENTS WITH CIRRHOSIS ADMITTED WITH ACUTE UPPER GASTROINTESTINAL BLEEDING	67
994 IMMUNOTHERAPY FOR ADVANCED HEPATOCELLULAR CARCINOMA, A SINGLE CENTER EXPERIENCE.	67
Su1646 CKD IS AN INDEPENDENT RISK FACTOR FOR DEVELOPING GASTROPARESIS	66
993 THE IMPACT OF SOCIAL RISK FACTORS ON THE PRESENTATION, TREATMENT AND SURVIVAL OF PATIENTS WITH HEPATOCELLULAR CARCINOMA AT AN URBAN, ACADEMIC SAFETY-NET HOSPITAL	66
Su1555 THE EFFECTIVENESS OF PEG 3350 COMPARED TO LACTULOSE FOR THE TREATMENT OF ACUTE HEPATIC ENCEPHALOPATHY IN ADULT CIRRHOTIC PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS	66
Mo1133 THE ROLE OF LIVER TRANSPLANT IN THE DEVELOPMENT OF COLORECTAL DYSPLASIA IN PATIENTS WITH PSC-IBD	66

Su1296 MUCOSAL IMPEDANCE ENABLES SCREENING FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) AFTER TREATMENT FOR ACHALASIA	66
658 KLEBSIELLA PNEUMONIAE TRANSLOCATION INDUCED LIVER TH17 CELL RESPONSE VIA CCL20 IN PRIMARY BILIARY CHOLANGITIS	66
Corrigendum	65
TOFACITINIB TREATMENT PREVENTS POST-OPERATIVE RECURRENCE OF CROHN’S DISEASE MODELED BY ILEOCECAL RESECTION IN HLA-B27 TRANSGENIC RATS	65
Mo1313 PATIENTS WITH ELEVATED UPPER ESOPHAGEAL SPHINCTER (UES) PRESSURES ARE LESS LIKELY TO PRESENT WITH ATYPICAL SYMPTOMS OF GASTROESOPHAGEAL REFLUX DISEASE	65
THE IMPACT OF CARDIAC ARRHYTHMIAS ON INFLAMMATORY BOWEL DISEASE (IBD)	64
Seladelpar as an Alternate Second-Line Agent for Primary Biliary Cirrhosis	64
VEDOLIZUMAB FOR REFRACTORY MICROSCOPIC COLITIS: A CASE SERIES	64
A Rare Cause of Abdominal Pain and Weight Loss	64
Colorectal Tumor Recurrence on a Mysterious Spot	63
First-Line Treatment Options for Ileocecal Crohn’s Disease: Early Surgical Resection or Biologics?	63
Repurposing UDCA, an FXR Inhibitor, to Prevent SARS-Cov-2 Infection	63
ADHERENT-INVASIVE E. COLI PROMOTE ER STRESS TO SUPPORT IL23R-DRIVEN AGR2-DEPENDENT ILEOCOLITIS	63
Improving Influenza Vaccination in Pediatric Inflammatory Bowel Disease: A Quality Improvement Initiative	62
Sa1827 PRE-COLECTOMY EXTRAINTESTINAL MANIFESTATIONS AND CROHN'S DISEASE LIKE POUCHITIS ARE SIGNIFICANTLY ASSOCIATED WITH THE DEVELOPMENT OF POST-ILEAL POUCH ANAL ANASTOMOSIS EXTRAINTESTINAL MANIFESTAT	62
EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE	62
456 PRECONCEPTION GUT DYSBIOSIS AFFECTS ENTERIC NERVOUS SYSTEM DEVELOPMENT AND FUNCTION OF OFFSPRING IN MICE	62
Su1787 EFFECT OF UPADACITINIB ON LIPID PROFILES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: POOLED ANALYSIS OF PHASE 3 INDUCTION AND MAINTENANCE STUDIES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE	61
Su1130 ASSOCIATION OF CARBOHYDRATE SULFOTRANSFERASE 15 AND PROGNOSIS IN UNRESECTABLE PANCREATIC CANCER TISSUE BIOPSIES BY ENDOSCOPIC ULTRASOUND-GUIDED FINE NEEDLE ASPIRATION	61
Tu1662 IRRITABLE BOWEL SYNDROME PATIENTS REPORT HIGHER SYMPTOM BURDEN IN END-OF-DAY VERSUS MOMENTARY ASSESSMENTS: RESULTS FROM A PSYCHOMETRIC VALIDATION STUDY	61
Tu1764 HIGH DIMENSIONAL PROFILING OF IL-23-RESPONSIVE CELLS REVEALED MOLECULAR SIGNATURES THAT PREDICT RESPONSE TO ANTI-IL-23 THERAPY IN PATIENTS WITH CROHN'S DISEASE	61
Sa1224 UPON EX VIVO EXPANSION INFLAMED INTESTINAL EPITHELIAL CELLS FROM ULCERATIVE COLITIS RESTORE A NON-INFLAMED TRANSCRIPTIONAL PROFILE	61
Tu1442 EFFECT OF SKELETAL MUSCLE MASS LOSS ON OUTCOMES OF PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS.	61
32 SIMPLE ENDOSCOPIC SCORE FOR CROHN'S DISEASE (SES-CD) ≥ 7 PREDICTS DISEASE PROGRESSION IN PATIENTS WITH MILD CD	60
Su1421 LONG-TERM PROGNOSIS INCLUDING CANCER DEVELOPMENT IN PATIENTS WITH CHRONIC PANCREATITIS: A MULTICENTER COHORT STUDY IN JAPAN	60
1123 GOBLET CELL ADENOCARCINOMA AND RESPONSE TO TREATMENT - SINGLE CENTER EXPERIENCE OF A RARE MALIGNANCY	60
Mo1239 ANALYSIS OF CHARACTERISTICS AND MICROBIOTA OF GASTRIC CANCER OCCURRING IN HIGH-RISK COUNTRIES	60
1222 THE ASSOCIATION OF SOCIAL VULNERABILITY INDEX AND COLORECTAL CANCER SCREENING RATE IN THE US	59
337 ANCESTRY-SPECIFIC GENETIC EFFECTS IDENTIFIED IN A COHORT OF HISPANICS WITH INFLAMMATORY BOWEL DISEASE	59
Sa1926 WASHED MICROBIOTA TRANSPLANTATION FOR REFRACTORY INTESTINAL INFECTIONS: FINDINGS FROM A NATIONAL MUTI-CENTER, REAL-WORLD STUDY	58
Sa1553 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND CLINICALLY SIGNIFICANT FIBROSIS ARE HIGHLY PREVALENT IN PCOS AND AN ALT >19 U/L IS THE OPTIMAL CUT-OFF FOR IDENTIFYIN	57
Su1145 PRIMARY SQUAMOUS CELL CARCINOMA OF THE GALLBLADDER IS EXTREMELY RARE AND ASSOCIATED WITH POOR SURVIVAL	57
Mo1663 TRANSFORMING DIABETIC GASTROPARESIS CARE IN WOMEN: INSIGHTS FROM NASAL METOCLOPRAMIDE USAGE	57
Tu1770 DISEASE DURATION IMPACTS INTESTINAL GENE EXPRESSION PROFILES IN CROHN'S DISEASE BUT NOT IN ULCERATIVE COLITIS	57
Sa1727 IMPLICATIONS OF SHAME FOR PATIENT REPORTED OUTCOMES IN FUNCTIONAL BOWEL DISORDERS	57
Su1240 P2X4 BLOCKADE AS A NEW THERAPEUTICAL STRATEGY TO RELIEVE VISCERAL PAIN IN A RAT MODEL OF COLITIS	57
Sa1823 DEVELOPMENT AND INTERNAL-EXTERNAL VALIDATION OF A DYNAMIC MULTIVARIABLE PREDICTION MODEL FOR ADVANCED COLORECTAL NEOPLASIA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE	56
Tu1954 INSULIN AND AMPK-MEDIATED ALTERATIONS IN DNA METHYLATION: IMPLICATIONS FOR OBESITY-ASSOCIATED COLORECTAL CANCER	56
702 MAGNESIUM IS THE MAJOR ACTIVATOR OF CALCIUM-SENSING RECEPTOR IN THE INTESTINE AND ITS SUPPLEMENTATION CAN TREAT SECRETORY DIARRHEA	55
758 BHLHE40 IN GROUP 3 INNATE LYMPHOID CELLS SHAPES TL1ADEPENDENT COMMENSAL T CELL IMMUNITY	55
765 RISK STRATIFICATION IN FIT-BASED COLORECTAL CANCER SCREENING: INTERVAL CANCER RISK AFTER THE UPPER AGE LIMIT OF SCREENING HAS BEEN REACHED	55
981 WESTERN DIET DEPLETES SMALL INTESTINAL INTRAEPITHELIAL LYMPHOCYTES VIA FXR-TYPE I INTERFERON PATHWAY	55
868 DISSECTING GUT-BRAIN AXIS: ALTERED MULTI-KINGDOM GUT MICROBIOME IN AUTISM SPECTRUM DISORDER	55
1162 TRANSCUTANEOUS AURICULAR VAGAL NERVE STIMULATION IMPROVES FUNCTIONAL DYSPEPSIA WITH SLEEP DISTURBANCE VIA ENHANCED VAGAL ACTIVITY	54
1169 CLINICAL UTILITY OF NEXT-GENERATION SEQUENCING FOR DIFFERENTIATING MAIN-DUCT INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM AND CHRONIC PANCREATITIS AS ETIOLOGY OF PANCREATIC DUCT DILATION	54
658 WOUND HEALING AFTER EPISIOTOMY AND CESAREAN SECTION AMONG WOMEN WITH IBD	54
1268 COMBINED BODY SURFACE GASTRIC MAPPING AND GASTRIC EMPTYING TESTING REVEALS DISTINCT PATIENT SUBGROUPS IN GASTROPARESIS	54
1282 EFFICACY OF STRUCTURAL INDIVIDUAL LOW FODMAP DIETARY ADVICE (SILFD) FOR GASTROESOPHAGEAL REFLUX DISEASE (GERD) : A RANDOMIZED TRIAL	53
1163 A NOVEL CLINICAL CLASSIFICATION SCHEME FOR GASTRIC ALIMETRY TESTING IN GASTRODUODENAL DISORDERS	53
836 THE USE OF SLEEVE GASTRECTOMY FOR ELDERLY AND FRAIL OBESE PATIENTS IS SAFE, AND IT RESOLVES THEIR COMORBIDITIES IN MOST CASES	53
1160 THE INTERPLAY BETWEEN DIET AND THE GUT MICROBIOME IN DETERMINING PLASMA C-REACTIVE PROTEIN LEVELS IN HEALTHY INDIVIDUALS	53
95 VALIDATION OF RISK ASSESSMENT TOOLS FOR THE DETECTION OF BARRETT'S ESOPHAGUS IN PATIENTS WITHOUT CHRONIC REFLUX SYMPTOMS	53
1257 CHIA DEFICIENCY IN THE CHIEF CELLS PROMOTES SPASMOLYTIC POLYPEPTIDE-EXPRESSING METAPLASIA THROUGH PYROPTOSIS MEDIATED M2 MACROPHAGE POLARIZATION	53
Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS WHO INITIATED A NEW JANUS KINASE INHIBITOR OR TUMOR NECROSIS FACTOR INHIBITOR USING DATA FROM A UNITED STATES CLAIMS DATABAS	53
Sa1546 ALARMING TRENDS IN ALCOHOLIC LIVER DISEASE RELATED MORTALITY AMONG AMERICAN INDIANS IN THE UNITED STATES FROM 1999-2020	52
Su1254 EPIDEMIOLOGY AND CHARACTERISTICS OF BARRETT'S ESOPHAGUS IN PATIENTS WITH AND WITHOUT GERD: A LARGE US POPULATION STUDY	52
Su1220 IDENTIFICATION OF A LOOSELY COUPLED REGION IN THE DISTAL RAT STOMACH AND ANTRAL RESPONSE TO CERVICAL VAGUS NERVE STIMULATION, DEFINED BY HIGH-RESOLUTION BIOELECTRICAL MAPPING	52
Su1436 POOLED CLINICAL OUTCOMES OF PANCREATITIS INDUCED SPLENIC VEIN THROMBOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS	51
Mo1922 BERBERINE IS NOT INFERIOR TO RIFAXIMIN IN TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN INTERIM ANALYSIS OF THE BRIEF-SIBO RCT STUDY	51
Su1697 ROBOTIC COLORECTAL RESECTIONS ARE ASSOCIATED WITH LESS POSTOPERATIVE PAIN AND REDUCED POSTOPERATIVE OPIOID USE COMPARED TO THE LAPAROSCOPIC APPROACH	51
Mo1022 ELECTRONIC CODING FOR ABNORMAL FECAL IMMUNOCHEMICAL TEST IS ASSOCIATED WITH INCREASED COLONOSCOPY COMPLETION	51
Su1444 ACTIVIN A SIGNALING STIMULATES INNATE IMMUNE CELL ACTIVATION IN PANCREATITIS	51
Tu1534 MULTICENTER COMPARISON OF ABBREVIATED MRI VERSUS ULTRASOUND FOR DETECTING EARLY-STAGE HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CIRRHOSIS	50
EP32 BISPECIFIC NANOBODY ENHANCES THE IMMUNE RESPONSE TO ANTIPD-L1 IN COLORECTAL CANCER BY BLOCKING CCL5/CCR5 AXISMEDIATED RECRUITMENT OF TREG	50
Mo1190 INVESTIGATING THE NEED FOR ADJUSTING OMEPRAZOLE DOSAGE AND TIMING POST-BARIATRIC SURGERY: A META-ANALYTICAL APPROACH	50
1117 OVERALL SURVIVAL OF PATIENTS WITH CLINICAL COMPLETE RESPONSE AFTER RADIOCHEMOTHERAPY FOR ESOPHAGEAL CANCER: SHOULD A WATCHFUL WAITING STRATEGY BE THE NEW STANDARD OF CARE?	49
Mo1246 DIFFERENCES IN GENETIC ANCESTRY AND PRESENCE OF GASTRIC PRECURSOR LESIONS IN INDIVIDUALS WITH EARLY AND AVERAGE ONSET GASTRIC CANCER	49
Sa1814 REAL-WORLD USE OF PATIENT REPORTED OUTCOME MEASURES AT A LARGE TERTIARY INFLAMMATORY BOWEL DISEASE CENTER	49
Sa1864 ORAL MICROBIOTA INCLUDING VEILLONELLA IS INVOLVED IN THE PREFERENTIAL COLONISATION OF THE INFLAMED GUT MUCOSA IN NEWLY DIAGNOSED ILEAL CROHN'S WITH PREDICTION POTENTIAL FOR ACTIVE DISEASE	49
Tu1528 IMPACT OF ANTICOAGULATION THERAPY ON OUTCOMES IN PATIENTS WITH CIRRHOSIS AND PORTAL VEIN THROMBOSIS: A LARGE-SCALE RETROSPECTIVE COHORT STUDY	49
Tu1300 ENDOSCOPIC SUTURE PLICATION FOR END-STAGE ACHALASIA SIGNIFICANTLY IMPROVES SYMPTOMS	49
Su1008 GASTRIC CANCER AND ITS PRECURSOR LESIONS: ADDRESSING THE ASIAN FALLACY	49
Tu1920 FECAL MICROBIOTA TRANSPLANT ENEMA AS A PROMISING TREATMENT IN METABOLIC SYNDROME: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL	48
225 MODELING THE TUMOR MICROENVIRONMENT OF EARLY AND LATE ONSET COLORECTAL CANCER USING PATIENT-DERIVED ORGANOIDS	48
Su1555 ASSOCIATION BETWEEN REDUCED LIVER AND NON-LIVER MORTALITY AND BARIATRIC SURGERY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)-RELATED LIVER CIRRHOSIS – IMPAC	48
Tu1430 AN ANALYSIS OF THE CLINICAL BURDEN AND ECONOMIC COSTS OF VENOUS THROMBOEMBOLISM DURING INPATIENT ADMISSIONS FOR PANCREATIC CANCER IN THE UNITED STATES	47
Su1724 RESECTION OF OLIGOPROGRESSIVE DISEASE IN DEFICIENT MISMATCH REPAIR COLORECTAL CANCER TREATED WITH IMMUNOTHERAPY	47
Mo1506 ONE-MONTH NATURAL HISTORY ASSESSMENT OF TH-CELL AXIS RELATED INFLAMMATORY CYTOKINES, IL-17 AND IL-22 AND THEIR ROLE IN ALCOHOL-ASSOCIATED LIVER DISEASE.	47
Tu1744 SPECTRUM OF HISTO-ENDOSCOPIC ACTIVITY IN ULCERATIVE COLITIS REVEALS A DISTINCT MUCOSAL TRANSCRIPTOME FOR HISTO-ENDOSCOPIC REMISSION	47
Mo1177 DOCUSATE IN THE MANAGEMENT OF CHRONIC CONSTIPATION: A SYSTEMATIC REVIEW AND META-ANALYSIS	47
Sa1617 RISING TRENDS IN HEPATITIS A HOSPITALIZATIONS IN THE U.S. A DECADE-LONG ANALYSIS WITH A FOCUS ON SOUTHERN STATES AND CAUCASIAN POPULATIONS	47
Mo1223 GENOMIC ANALYSIS OF SIGNALING PATHWAYS DURING MULTISTEP PROCESSES OF HELICOBACTER PYLORI-INDUCED GASTRIC CANCER DEVELOPMENT	47
Su1280 CLINICAL DEVELOPMENT OF AQ280, A POTENT AND HIGHLY SELECTIVE JAK1 INHIBITOR, FOR THE TREATMENT OF EOSINOPHILIC ESOPHAGITIS	47
Sa1801 LONG-TERM OUTCOMES OF MODIFIED SIDE-TO-SIDE STRICTUREPLASTY IN CROHN'S DISEASE PATIENTS WITH EXTENSIVE ILEITIS CANNOT BE PREDICTED BY SIMPLIFIED MARIA SCORE	46
Su1996 ELUCIDATING THE DIURNAL PATTERN OF INTESTINAL GAS PRODUCTION AND ITS RELATIONSHIP TO STOOL FORM AND SYMPTOMS	46
Sa1354 HELICOBACTER PYLORI TREATMENT REDUCES THE RISK OF GASTRIC CANCER FOR HIGH GENETIC RISK POPULATIONS: A LONGITUDINAL STUDY	46
39 SINGLE-CELL RNA PROFILING AND HIGH-THROUGHPUT SCREENING DISCOVERED MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA AND HISTAMINE 1 RECEPTOR AS KEY PATHWAYS IN C. DIFFICILE INFECTION.	46
Su1638 THE DUODENAL MUCOSA-ASSOCIATED MICROBIOTA OF PATIENTS WITH A DISORDER OF GUT-BRAIN INTERACTION CAN BE DIFFERENTIATED BY ROME IV CRITERIA	46
Sa1803 NOVEL UTILITY OF LEUCINE-RICH ALPHA-2-GLYCOPROTEIN AS A BIOMARKER IN ULCERATIVE COLITIS: A PREDICTOR OF ENDOSCOPIC REMISSION INDEPENDENT OF SYMPTOMS	46
Sa1024 THE IMPACT OF HOMELESSNESS ON ENDOSCOPY UTILIZATION, SURGICAL TREATMENT, AND POST-OPERATIVE COMPLICATIONS AMONG HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS	45
BIOLOGIC TREATMENT DE-ESCALATION IN PATIENTS WITH CROHN’S DISEASE IS COMMON IN THE UNITED STATES	45
Sa1015 RACIAL AND ETHNIC DISPARITIES IN COST-RELATED BARRIERS TO MEDICATION ADHERENCE AMONG PATIENTS WITH IBD ENROLLED IN THE NATIONAL INSTITUTES OF HEALTH ALL OF US RESEARCH PROGRAM	45
ENTEROENDOCRINE CELLS REGULATE BARRIER INTEGRITY AND PROTECT AGAINST DSS-INDUCED OUTCOMES	45
Enterochromaffin Cells: Small in Number but Big in Impact	45
COMPARATIVE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS WITH VEDOLIZUMAB VS USTEKINUMAB IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASE: A PROPENSITY-MATCHED COHORT ANALYSIS	45